CARDIOPHOENIX

CardioPhoenix is an evidence-based innovation and research company for diagnostic cardiology. Their commitment is to earlier detection of the onset of heart disease and detection of a broader range of the most common heart diseases capable of being diagnosed at the clinical level. They have developed unique, evidence-based, analysis algorithms and a risk assessment assistance system for physicians to assist them to better determine cardiac status and establish a baseline for patient heart health. Today, the company portfolio of diagnostic algorithms supports clinical accuracy and advanced analysis that may lead to more confident diagnoses and better outcomes for the diverse, universal, patient population in the physician’s office. CardioPhoenix is based in Markham, ON, Canada.